Journal
PRION
Volume 2, Issue 3, Pages 112-117Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/pri.2.3.7488
Keywords
fibril; beta-sheet; aggregation; Alzheimer's disease; fibre diffraction; ssNMR; small angle X-ray scattering
Categories
Funding
- BBSRC
- Alzheimer's research trust
- Royal Society
- Wellcome Trust
Ask authors/readers for more resources
Amyloid refers to the abnormal fibrous, extracellular, proteinaceous deposits found in organs and tissues. Amyloid is insoluble and is structurally dominated by beta-sheet structure. Unlike other fibrous proteins it does not commonly have a structural, supportive or motility role but is associated with the pathology seen in a range of diseases known as the amyloidoses. These diseases include Alzheimer's, the spongiform encephalopathies and type II diabetes, all of which are progressive disorders with associated high morbidity and mortality. Not surprisingly, research into the physicochemical properties of amyloid and its formation is currently intensely pursued. In this chapter we will highlight the key scientific findings and discuss how the stability of amyloid fibrils impacts on bionanotechnology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available